You are here

Covaxin

FDA lifts hold on Ocugen's COVID-19 vaccine trial. But is it too late for the shot?

FDA lifts hold on Ocugen's COVID-19 vaccine trial. But is it too late for the shot?

Fierce Pharma

Flag link:

Ocugen hits another snag in bringing its Bharat Biotech-partnered Covid-19 vaccine to the US

Ocugen hits another snag in bringing its Bharat Biotech-partnered Covid-19 vaccine to the US

Endpoints

Flag link:

Is Ocugen About to Beat Moderna in This One Market?

Is Ocugen About to Beat Moderna in This One Market?

Motley Fool

Moderna Therapeutics

Flag link:

2 Biotech Stocks That Could Go Parabolic This Week

2 Biotech Stocks That Could Go Parabolic This Week

Motley Fool

Aurinia Pharmaceuticals

Flag link:

Ocugen preps filings for COVID-19 vaccine Covaxin on new data

Ocugen preps filings for COVID-19 vaccine Covaxin on new data

Pharmaforum

Flag link:

Ocugen plans to seek full approval for Covaxin in US

Ocugen plans to seek full approval for Covaxin in US

Pharmaceutical Business Review

Flag link:

Valneva joins the phase 3 Covid-19 vaccine club

Valneva joins the phase 3 Covid-19 vaccine club

EP Vantage

clinical trials

Flag link: